Sanofi sees faster profit growth on Dupixent, flu vaccine
Sanofi reported a 26.5 per cent rise in third-quarter business operating income, or adjusted earnings before interest and tax, to…
Author
US FDA extends review of Amicus muscle disorder therapy for second time
The agency blamed the delay on pandemic-related travel restrictions that kept it from conducting a required manufacturing site…
US government to test Pfizer’s Paxlovid for long COVID
The Duke Clinical Research Institute is supervising the study, which is scheduled to start on 1st January
GSK to bounce regulatory submissions for experimental arthritis drug
In a late-stage study, the antibody-based drug, otilimab, did not make a meaningful difference to improving swelling and…
Johnson & Johnson’s blood cancer therapy gets US FDA approval
J&J's teclistamab, branded as Tecvayli, is approved for treating adults with multiple myeloma that is hard to treat, or has…
Pfizer COVID vaccine price hike seen giving revenue boost for years
The drugmaker, which developed and sells the vaccine with Germany's BioNTech said last week that it is targetting a range of $110…
Three pharma companies recall products in US
The three pharma companies -- Dr Reddy's Laboratories, Cipla and Aurobindo Pharma -- are recalling different products in the US…
Indonesia considers prosecutions over cough syrup suspected of links to child deaths
Authorities have temporarily banned sales of some syrup-based medications and identified the presence in some products of ethylene…
AstraZeneca drug fails one main goal in study of chronic immune disease
Despite the setback from the trial, AstraZeneca said it would continue to analyse the complete data set, which included 210…